Document:

EX-10.13

 Exhibit 10.13 

 

					
		 		  	Axcan Intermediate Holdings Inc.
		 		  	22 Inverness Center Parkway
		 		  	Suite 310
	AXCAN PHARMA	 		  	Birmingham, AL 35242 USA
			
		 		  	Tel.: (205) 991-8085
		 		  	1-800-815-4393
		 		  	Fax: (205) 991-0639
			
		 		  	www.excan.com

 February 17, 2011 
 PERSONAL & CONFIDENTIAL. 
 Jean-Louis Anspach 

3225 Beechwood Drive 
 Marietta, GA 30067

 Dear Jean-Louis: 
 We are pleased
to make you this offer to join Axcan Intermediate Holdings, Inc. (“Axcan”) and our Combined Companies (Axcan and Eurand N.V and Eurand Pharmaceuticals, Inc.) in the position of President, International Specialty Pharmaceuticals, effective
February 21, 2011. As a member of our Senior Management Team you will be reporting to me. 
 As President, International Specialty
Pharmaceuticals, you will be responsible for building Axcan’s business in the European Union and other select markets, including the Canadian market. You will be accountable for planning, directing and controlling all activities, policies and
developments of Axcan’s International Specialty Pharmaceutical business. Additionally, you will actively participate in creating and implementing growth strategies and personnel activities for this area of our business in order to meet
corporate revenue and profit objectives. Further, you will be responsible for Axcan’s Global Strategic Marketing function, and perform any other duties and responsibilities that are consistent with your position and as may reasonably be
assigned by the Axcan from time to time. 
 In this position, your annual base salary will be $341,250 U.S. or 252,388 Euros and will be
reviewed annually thereafter, in accordance with the policies of the Company at the end of each fiscal year which ends September 30. You will also participate in Axcan’s Short-Term Incentive Plan, prorated for FY 2011 based on the length
of time in the position. Your target bonus is 45% of your annual base salary. Bonuses are earned; not guaranteed, and are based on corporate and individual performance as well as the individual’s compliance with Company policies. 

In accordance with the Retention Plan Agreement dated September 20, 2010, and the First Amendment to the Retention Plan Agreement dated
November 28, 2010 (together, the “Retention Agreement and Amendment”), you will receive a cash payment of $295,750, representing 25% of the “Retention Payment” and the “Additional Payment” under the Retention
Agreement and Amendment, as soon as administratively possible following the “Closing Date” of February 11, 2011. Additionally, following the six-month anniversary of the Closing Date, you will receive a one-time cash payment of
$159,250. Please note that, except as provided below, this payment is subject to “your continued employment with Axcan and represents the final payment under the Retention Plan Agreement and Amendment. If your employment is terminated by Axcan
other than for Cause (as such term is defined in the Retention Agreement and Amendment) prior to your receipt of this payment, you will be entitled to receive $159,200 in cash “on the next regular payroll date immediately following the date of
termination. 

 You will also participate in Axcan’s Long-Term Incentive Plan. Under this program, you will be eligible
to receive a one-time grant of 200,000 options (at an exercise price of $10) to purchase shares of our parent company, Axcan Holdings Inc. A copy of the Long-Term Incentive Plan, and the award agreement that will govern your grant, will be provided.
Subject to Board approval, these options will be awarded as soon as reasonably possible following your acceptance of this offer, in compliance with the Company policy related to equity grants. 

As you may know, many of the Senior Management and Leadership Team members have invested in our business by purchasing shares of our parent company. We
are providing an opportunity for you to purchase up to 29,640 Shares from Axcan Holdings Inc. for an aggregate investment of $296,400 U.S., subject to your executing a subscription agreement and the Management Stockholders’ Agreement which will
be provided to you. It is expected that all members of the Management Team will take advantage of this opportunity and make an investment in the parent company. 
 Further details of the Long-Term Incentive Plan and the opportunity to invest in shares will be provided to you separately upon acceptance of this offer. 

You will be entitled to participate in benefit programs currently offered to you and any benefit programs and perquisites of Axcan which are generally
made available to other Senior Management employees of Axcan. This includes a company car or car allowance of $10,200 U.S. per year. 

Initially, you will work in the United States in one of the Company’s facilities for 12-18 months. You will be expected to relocate to Axcan’s
European office (location to be determined), and complete the relocation by August 31, 2012. 
 Upon relocation, Axcan will compare the
retirement program available to you to determine what, if any, additional plan is needed to give a comparable benefit you have under the Company’s 401(k) plan. 
 The Company will also provide you a full relocation package to assist you with the movement of your household goods, and other relocation needs. General details regarding the relocation support are
attached. 
 Additionally, if Axcan terminates your employment by reason of a Change of Control (as such term is defined in the Management
Equity Incentive Plan, a copy of which will be provided, within twelve (12) months following the Change of Control and does not offer you a comparable position, or if you resign your employment for Good Reason (as such term is defined in the
Management Equity Incentive Plan), you shall be offered, in return for your execution of a general release, a lump sum severance payment equivalent to twelve (12) months of your base salary and target annual bonus, as of the date of
termination. 
 Both during the course of your employment with us, as well as after, you will undertake to keep confidential all information or
trade secrets relating to our organization except where required in the normal course of business during the course of your employment; or as required by applicable law. Your signing appropriate confidentiality, intellectual property,
non-solicitation and non-competition agreements is a condition of your employment, in accordance with Company policies. 
 You agree that this
letter contains your sole and entire agreement regarding the subject matter herein, and supersedes any and all prior agreements and understandings between you and the Company, including agreements between you and Eurand as well as statements and
representations of the parties, including, but not limited to, any employment or other agreement regarding your compensation or terms of employment entered into prior to the effective date. For the avoidance of doubt, the parties

 
acknowledge that the foregoing sentence shall: (i) apply to the Retention Plan Agreement between the parties dated September 20, 2010, the First Amendment to the Retention Plan
Agreement dated November 28, 2010 and the Executive Change in Control Agreement between the parties dated June 1, 2010 and (ii) not be applicable prior to the effective date. Notwithstanding the foregoing, any Proprietary Information
and Inventions Agreement (or similar agreement), or indemnification Agreement, that you have previously executed shall remain in full force and effect. 
 If you require further clarification regarding your employment package and the terms thereof, please do not hesitate to contact me. If you agree to the terms and conditions in this letter, please sign in
the space provided and return the third page of this letter to Rick Devleeschouwer via fax (908) 252-2026 or email to rdevleeschouwer@axcan.com. We would appreciate receiving a response to this offer by 5:00 p.m. ET on February 18, 2011,
at which time this offer of employment expires. 
 Jean-Louis, please do not hesitate to contact me to discuss further. We are looking forward
to having you as a member of our Senior Management Team. 
  

	
	Best regards,
	
	/s/ Frank Verwiel
	Frank Verwiel M.D
	President and Chief Executive Officer

 PLEASE READ CAREFULLY BEFORE SIGNING 

I understand that this offer does not constitute a contract of employment, express or implied, guaranteeing employment for any specific duration. I
acknowledge that my employment relationship with Axcan Pharma is on an at-will basis. Both Axcan Pharma and I may terminate my employment at any time, for any reason, with or without cause or prior notice. I further understand that Axcan Pharma
reserves the unrestricted right to change or modify any available fringe benefits at any time without prior notice and that Axcan Pharma reserves the discretionary authority to interpret all provisions of employment and available fringe benefits.

 I understand that by accepting this position with Axcan Pharma, I represent and confirm that I am not in breach of any agreement entered into
with any other party including, without limitation, any agreement relating to confidentiality of information, property, of information, Intellectual property, non-competition, non-solicit or other restrictive covenants. 

I understand that no supervisor, manager, or representative of Axcan Pharma other than the President and Chief Executive Officer has the authority to
enter into any agreement with me for employment for any specified period or to make any promises or commitments contrary to the foregoing Agreement. Further, I acknowledge that any such employment agreement shall not be enforceable unless it is in
writing. 
 By signing this letter, I agree that Axcan Pharma has made no promises other than those outlined in this letter. 

 

	
	ACCEPTED
	
	/s/ Jean-Louis Anspach
	Jean-Louis Anspach
	
	02-18-2011
	Date

 EXHIBIT A 
 RELOCATION 
 As a result of the relocation of you and your family to Europe, Axcan will
provide the following support: 
  

	1.	A one time relocation allowance equivalent to two months base salary net of taxes, payable following relocation. All costs of a physical relocation firm to assist you
and your family with the choice of which neighborhood to live in. 

  

	2.	Temporary living assistance for an initial period of 60 days for all reasonable expenses for meals, lodging, laundry, auto rental and associated expenses incurred by
you in your new location, prior to moving into a permanent residence. 

  

	3.	Home Marketing Assistance (HMA): As part of the relocation package, HMA provides assistance to you for the marketing and sale of your home. A Relocation Consultant
assigned by Axcan will provide expertise to you to market your Property with local real estate assistance which includes counseling on establishing a list price, marketing strategies, contract negotiations and assistance in closing the sale of the
Property. 

 As part of the HMA, upon receipt of proper documentation, Axcan will reimburse the following expenses
actually incurred by the employee in connection with the sale of a current home: 
  

	 	•	 	 Reasonable attorneys’ fees 

  

	 	•	 	 Federal, state, and local transfer taxes 

  

	 	•	 	 Search fees and/or title insurance where local custom dictates 

 

	 	•	 	 Brokerage commission of a licensed real estate broker, maximum of 6% 

 

	 	•	 	 Mortgage prepayment penalties 

  

	 	•	 	 Notary and acknowledgement fees, tax certificate, recording fees and survey costs 

 

	 	•	 	 One appraisal, and 

  

	 	•	 	 Other settlement costs approved in advance by the Company. 

 

	4.	Home Finding 

 All actual,
reasonable expenses incurred for two home finding trips between the old and new location will be reimbursed. Reimbursable expenses will include transportation (economy airfare), lodging and meals for the employee, spouse, and dependent children.
Reimbursement will be limited to a maximum of three days per trip, exclusive of travel time. 
  

	5.	Moving of Household Goods and Personal Effects 

 The Company will pay the costs of moving household effects, including pets and one car from the old principal residence to the new principal residence. This includes expenses covered by the Company for
moving household goods including packing, moving, unpacking, and insurance coverage for moving the household goods and personal effects of the employee from the old residence to the new residence. A moving company selected by the Human Resources
Department will handle the movement of household goods. You should not contact any moving companies; solicit estimates or make moving arrangements. Necessary and reasonable costs to be provided for the storage of items at the point of destination
for a maximum of three months. 

	6.	Necessary and reasonable closing costs in buying a home at the new location as outlined below. 

 

	 	•	 	 Reasonable attorneys’ fees 

  

	 	•	 	 Mortgage lender service fees, including origination fees and loan assumption fees 

 

	 	•	 	 Mortgage application fees 

  

	 	•	 	 Title insurance fees 

  

	 	•	 	 Appraisal fees 

  

	 	•	 	 Mortgage tax 

  

	 	•	 	 Real Estate transfer tax 

  

	 	•	 	 Recording fees, deeds and mortgage, etc. 

  

	 	•	 	 Survey expenses, if required by lender 

  

	 	•	 	 Termite and structural inspection fees, if required by lender 

 

	 	•	 	 Credit report expense, if required by lender 

  

	 	•	 	 Notary fees 

  

	 	•	 	 Document preparation 

  

	7.	Housing Allowance: Axcan will provide housing assistance of 24,000 Euros net of taxes annually for four years from the date of relocation. You must provide the Company
with a copy of the lease or mortgage agreement to receive payment of the housing allowance. 

  

	8.	Education:Allowance: Axcan will assist with tuition reimbursement for school-age children through grade 12 for four years from the date of relocation.

  

	9.	Travel: Axcan will reimburse economy air travel for one round trip each year for four years from the date of relocation for employee and immediate family from Europe to
the United States (Georgia or New Jersey). 

  

	10.	Tax Preparation assistance for four years following the relocation not to exceed USD $5,000 per year. 

 

	11.	All relocation expenses must be approved by the Human Resources Department and submitted on an expense report separate from business expenses.EX-10.14

 Exhibit 10.14 
 AXCAN PHARMA 
  

			
		  	 Axcan Pharma US, Inc.
 721
Route 202-206

1st Floor
 Bridgewater, New Jersey USA
 Telephone (908) 927-9600
 Facsimile  (908) 927-9648

www.axcan.com

 March 27, 2009 
 Ms. Theresa Stevens 
 4635 Maiden Forest Road 

Rhodesdale, MD 21659 
 Dear Theresa: 

We are delighted to extend this offer of employment to you as Senior Vice President, Business Development, effective June 1, 2009, As a member of
the Management Team, you will report to Dr. Frank Verwiel, President and Chief Executive Officer and be positioned in the Company’s Bridgewater, New Jersey office. 
 As Senior Vice President, Business Development, you will be responsible for increasing sales and profitability of the Company through strategic direction and effective management of the global business
development function. You will also be responsible for successfully identifying and pursuing strategic and tactical business opportunities, mergers, acquisitions, partnerships, alliances, joint ventures, and overseeing assessment and negotiations to
bring the right opportunities to fruition. 
 In this position, your annual base salary will be $320,000 and will be reviewed annually
thereafter, in accordance with the policies of the Company. In addition, you will participate in Axcan’s Short-Term Incentive Compensation Plan effective FY2009, prorated based on length of time in your position. For FY2009, this position has
an annual incentive target of 45% of base salary. Bonuses are earned, not guaranteed and are based on Company and individual performance. 
 You
will also receive a special signing bonus of $35,000. This signing bonus will be paid to you as soon as reasonably possible following your employment date and is with the stipulation that should you leave the Company within 12 months from the first
day of work, you will repay $35,000 and if you leave between the 13th to 18th month from the first day of work, you will repay $10,000 of this amount. 
 The Company is also pleased to award you with a one-time grant of 160,000 stock options, subject to Board approval. Details of the Management Equity Incentive Plan will be provided to you upon your
acceptance of this offer. 
 You will be entitled to the full range of benefits extended to the senior management team and all U.S. employees at
large, not limited to but including health and dental insurance, life insurance, disability insurance, and a 401 (k) retirement plan. The cost of employee 
 only coverage is $3.00 per month. The cost of family coverage is $120.00 per month. Any amount due will be deducted from the last paycheck each month. Under the Company’s plan following a 30-day
waiting period, new employees and any covered dependents become eligible for coverage on the first day of the month after completing the waiting period. Based on your employment date of June 1, 2009, after completion of the appropriate forms,
you will be eligible for coverage July 1, 2009. 

 Theresa Stevens 
  Page
 2
 
  

 You will also have an annual vacation allowance of four (4) weeks, prorated for 2009 and the week
between Christmas and New Year’s. Eligibility for vacation accrual extends January 1 to December 31. A summary of the benefits is attached for your review and I will be happy to answer any questions you may have in this regard. You
will also be eligible to the usual perquisites available to the members of the management team including a Company car or Company car allowance of $10,200 US. 
 Additionally, if the Company should terminate your employment or you resign within ninety (90) days after having your job responsibilities or base compensation materially reduced following a change
of control, you shall be offered, in return for your execution of a general release, a lump sum severance payment equivalent to 12 months of your base salary. This is provided that you give the Company written notice of the existence of the
condition within ninety (90) days of its initial existence and the Company fails to cure the condition within thirty (30) days of receiving your written notice; and your termination of employment occurs on or within 24 months after a
change of control and the acquiring or resulting company does not offer you a comparable position. 
 For the purposes of this agreement, Change
of control is defined as: (1) the acquisition of a majority of the voting shares of the Company by a person or organization acting individually or in concert; (2) a merger in which the Company is not the surviving entity or in which the
Company’s stockholders immediately before the merger do not afterward control a majority of the voting or equity interests of the surviving entity; (3) a sale of all or substantially all of the Company’s assets; (4) a change in
the composition of the Board of Directors such that a majority of the Company’s Directors are replaced over any period of two years by Directors whom the Directors did not nominate; and/or (5) liquidation or dissolution of the Company.

 Both during the course of your employment with us, as well as after, if applicable; you will undertake to keep confidential all information
or trade secrets relating to our organization except where warranted in the normal course of business. We Will provide a confidentiality agreement for your signature. 
 By accepting this position with the Company, you represent and confirm that you are not in breach of any agreement entered into with any other party including, without limitation, any agreement relating
to confidentiality of information, property of information, Intellectual property, non competition, non solicit or other restrictive covenant. 

As part of the pre-employment process, all of the matters set out herein are conditional upon successfully passing a hair sample drug test and final
background checks. 

 Theresa Stevens 
  Page
 3
 
  

 I have tried to include all the details regarding your employment package. If further clarification is
needed, please call me at (205) 991-8085 Office or (205) 999-0724 Mobile. If you agree to the terms and conditions in this letter, please sign in the space provided and return the third page of this letter to me in the Birmingham Office
via fax (205) 991-0639 by March 30, 2009. 
 Theresa, we are excited that you are considering joining our organization. I look
forward to working with you. 
  

	
	Sincerely, 
	
	/s/ Martha D. Donze
	 Martha D. Donze
 Vice
President
 Corporate Administration

 Attachments 

CC: Dr. Frank Verwiel 

 Theresa Stevens 
  Page
 4
 
  

 PLEASE READ CAREFULLY BEFORE SIGNING 

I understand that this offer does not constitute a contract of employment, express or implied, guaranteeing employment for any specific duration. All
employment relationships with Axcan Pharma are on an at-will basis. Both Axcan Pharma and I are free to terminate my employment at any time, for any reason, with or without cause, or prior notice. I understand that this offer and my employment are
contingent upon passing a hair sample drug test. I further understand that Axcan Pharma reserves the unrestricted right to change or modify any available fringe benefits at any time without prior notice and that Axcan Pharma reserves the
discretionary authority to interpret all provisions of employment and available fringe benefits. 
 I understand by accepting this position with
the Company, I represent and confirm that I am not in breach of any agreement entered into with any other party including, without limitation, any agreement relating to confidentiality of information, property of information, Intellectual property,
non competition, non solicit or other restrictive covenant. 
 I understand that no supervisor, manager, or representative of Axcan Pharma other
than the President or Vice President, Corporate Administration has the authority to enter into any agreement with me for employment for any specified period or to make any promises or commitments contrary to the foregoing. Further, any employment
agreement entered into by the President or Vice President, Corporate Administration shall not be enforceable unless it is in writing. 
 By
signing this letter, the Employee also agrees that Axcan Pharma has made no promises other than those outlined in this letter. 
  

	
	ACCEPTED
	
	/s/ Theresa Stevens
	Theresa Stevens
	
	3/27/09
	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}]]